Ranjan Batra

Ranjan Batra currently serves as Chief Scientific Officer at Dyne Therapeutics since April 2025, following a role as Vice President of Discovery, Research, and Translation at Lexeo Therapeutics from January 2024 to April 2025. Prior to these positions, Ranjan was Senior Vice President of R&D at Locanabio, Inc. from March 2018 to February 2024, where responsibilities included drug development and research strategy focused on rare genetic diseases. Ranjan's career also includes experiences as Vice President of Research and Development at Locanabio, Inc., Scientist at Verily Life Sciences, and multiple postdoctoral roles at prestigious institutions including the University of California, San Diego, Mayo Clinic, and the University of Florida. Ranjan holds a PhD in Human/Medical Genetics from the University of Florida, a Master's degree in Pharmacology from The Ohio State University, and a Bachelor's degree in Pharmacy from Delhi University.